EichorEICHOR
Location: Dubois Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Dubois

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (CO
Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT07177339A Study to Evaluate Solrikitug in Participants With COPD (ZION)
Phase 2 · Clinical Research Associates of Central PA · Uniquity One (UNI) · NCT06496620AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obst
Phase 3 · Clinical Research Associates of Central PA, LLC · Novo Nordisk A/S · NCT07571005A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chro
Phase 4 · Clinical Research Associates of Central Pennsylvania- Site N · Sanofi · NCT07053423A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older Wi
Phase 2 · Research Site · AstraZeneca · NCT07088926To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
Phase 2 · Clinical Research Associates of Central PA, LLC · Expedition Therapeutics, Inc · NCT07684820Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-Hi
Phase 2 · Research Site · AstraZeneca · NCT06932263A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD
Phase 3 · Clinical Research Associates Of Central Pa , Llc · Hoffmann-La Roche · NCT05878769Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontroll
Phase 3 · Research Site · AstraZeneca · NCT06750289myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
NA · Clinical Research Associates of Central Pennsylvania · Temple University · NCT05204888Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
Phase N/A · Clinical Research Associates of Central PA · Freenome Holdings Inc. · NCT06122077Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Di
NA · Clinical Research Associates of Central Pennsylvania · bioAffinity Technologies Inc. · NCT07168993The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
Phase 3 · Clinical Research Associates of Central PA · Boehringer Ingelheim · NCT06872892Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
NA · Penn Highlands - Lung Innovations/Clinical Research Associat · Nuvaira, Inc. · NCT07051707A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis
Phase 2 · GSK Investigational Site · GlaxoSmithKline · NCT07201051A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary
Phase 2 · Research Site · AstraZeneca · NCT07082738Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants
Phase 2 · Clinical Research Associates of Central PA, LLC · Altesa Biosciences, Inc. · NCT07610395Quality of Life and Economic Repercussions of Combining Proactive Medication Assessment and Electronic Monitoring of Tox
NA · Centre Hospitalier Universitaire de Nīmes · NCT05345587Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic
Phase 3 · Clinical Research Associates of Central PA · PureTech · NCT07284602A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopul
Phase 3 · Research Site · AstraZeneca · NCT06283966A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D
Phase 3 · Research Site · AstraZeneca · NCT06883305A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Phase 2 · Clinical Research Associates of Central PA, LLC · Pfizer · NCT06977581Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
NA · Clinical Research Associates of Central Pennsylvania · Apreo Health, Inc. · NCT06891755A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or
Phase 3 · Research Site · AstraZeneca · NCT07667803Innovations in Genicular Outcomes Registry
Phase N/A · Penn Highlands DuBois · Pacira Pharmaceuticals, Inc · NCT05495334Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT06979323Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and T
Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT06961214AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obst
Phase 3 · Clinical Research Associates of Central PA, LLC · Novo Nordisk A/S · NCT07571109A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmo
Phase 2/Phase 3 · Clinical Research Associates of Central PA, LLC · Pfizer · NCT07363694
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.